Spike in Bruker Q2 Revs
Bruker announced this week a 30.6 percent increase in revenues for its second quarter ended June 30.
For the quarter, the company posted receipts of $311.5 million, compared to $238.3 million a year ago. Currency effects contributed 12 percentage points to the results.
Profits rose 22.8 percent to $21.7 million, compared to $17.7 million a year ago. During the second quarter of 2008, Bruker repaid $158 million of debt related to its acquisition

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

NPR reports that government and private insurers are being slow to cover recently approved CAR-T cell therapies.

Sponsored by

This webinar will discuss an automated, high-throughput method of generating high-quality antigens and antibodies.